Review
Epigenetic biomarkers for disease susceptibility and preventative medicine
Cell metabolism
01/03/2024
PMID: 38176413
Abstract
The development of molecular biomarkers for disease makes it possible for preventative medicine approaches to be considered. Therefore, therapeutics, treatments, or clinical management can be used to delay or prevent disease development. The problem with genetic mutations as biomarkers is the low frequency with genome-wide association studies (GWASs), generally at best a 1% association of the patients with the disease. In contrast, epigenetic alterations have a high-frequency association of greater than 90%-95% of individuals with pathology in epigenome-wide association studies (EWASs). A wide variety of human diseases have been shown to have epigenetic biomarkers that are disease specific and that detect pathology susceptibility. This review is focused on the epigenetic biomarkers for disease susceptibility, and it distinct from the large literature on epigenetics of disease etiology or progression. The development of efficient epigenetic biomarkers for disease susceptibility will facilitate a paradigm shift from reactionary medicine to preventative medicine.
Metrics
10 Record Views
Details
- Title
- Epigenetic biomarkers for disease susceptibility and preventative medicine
- Creators
- Michael K Skinner - Washington State University
- Publication Details
- Cell metabolism
- Academic Unit
- Biological Sciences, School of
- Identifiers
- 99901080305001842
- Language
- English
- Resource Type
- Review